Result-oriented with 12+ years post -PhD experiences as a synthetic Organic Chemist in well reputed academic research lab and CRO industry. Overseeing a team 30+ chemists including 3 project leaders, spanning over 4 chemistry collaboration with international pharmaceutical company. Excelled in strategic planning and team development, enhancing productivity by implementing efficient workflows. Significantly optimizing project outcomes and stakeholder satisfaction. Capable of working with a diversified functional team and able to demonstrate a good team spirit.
· Preparing business proposals based on RFQ’s
· Project managements by using project tracker and acting as bridge between all the stake holders
· Client communication internally and globally on regular basis to follow the progress of the projects and bottlenecks.
· De-bottlenecking of problems faced during project performance by submission of alternate proposals, re-prioritization of resources
· Reviewing and communication weekly/bi-weekly/monthly reports of the progress of the projects to internal clients and higher management
· To develop & design synthetic routes for new compounds or modify the old route by utilizing a blend of both classical and modern technology effectively.
Team management
Safety evaluation
Strategic Planning
Client communication
Complex Small Molecule
Natural products
API
List of Publications:
1. In(OTf)3 catalyzed synthesis of 4-thiocyanotetrahydropyrans via three component reaction. Yadav, J.S.; Reddy, B.V.S.; Maity, T. Naryanakumar, G. G. K.S.; Tetrahedron Letters, 2007, 48, 8874–8877.
2. A diastereoselective synthesis of 4-azidopyrans via the Prins-cyclization. Yadav, J.S.; Reddy, B.V.S, Maity, T.; Naryanakumar, G. G. K.S.; Tetrahedron Letters, 2007, 48, 7155–7159.
3. Three-component coupling of aldehydes, homoallyl alcohols, and trimethylsilyl azide: A facile synthesis of 4-azidotetrahydropyrans via the Prins cyclization. Yadav, J.S.; Reddy, B.V.S.; Maity, T.; Naryanakumar, G. G. K.S.; Synthesis, 2008, 17, 2739-2742
4. Towards the synthesis of (-)-Callipeltoside A: stereoselective synthesis of the C1-C14 mactrolactone Core. Yadav, J. S.; Haldar, A.; Maity, T..European Journal of Organic Chemistry, 2012, 2062-2071.
5. Towards the synthesis of Lyngbyaloside-B, Yadav, J. S.; Haldar, A.; Maity, T. European Journal of Organic Chemistry, 2013, 3076-3085.
6. Total synthesis of (-)-Leptomycin B. Yadav, J. S.; Maity, T.; Haldar, A. Communicated in Organic Letter
7. Towards the synthesis of of Callystatin A. Yadav, J. S.; Maity, T.; Haldar, A. Communicated in Journal of Organic Chemistry.
8. Total synthesis of Natural product (-)-Delactonmycin via palladium catalzsed epoxide opening. Yadav, J. S.; Maity, T.; Haldar, A. Manuscript under preparation.
9. Total synthesis of (-)-Denticulatins B. Jhillu S.Yadav, Maity, T, Animesh Haldar. Manuscript underpreparation.
Patent: An improved process for the preparation of peroxetine and its intermediate. WO 2017/037662, PCT/IB2016/055261
Presentation
“Towards the synthesis of Leptomycin-B and application of Desymmetrization towards the synthesis ofDenticulatin A & B” Yadav, J. S.; Maity,T.(poster)CRSI-RSC symposium in chemistry IICT, Hyderabad, India, 4th-7th February, 2010.
Awards and Fellowship
· Qualified SRF-CSIR for Senior Research Fellowship 2008.
· Qualified in the Graduate Aptitude Test in Engineering (GATE, 2005), A National test for Research fellowships, India. 2006.
· Awarded the National Junior Research Fellowship from the Council of Scientific and Industrial Research (NET-CSIR Dec’ 2005), New Delhi, Govt. of India, through a 2005 nationally conducted examination.
References:
Dr. J. S. Yadav, CSIR-Bhatnagar Fellow, (Ex-Director IICT), FNA,,FTWAS, IICT)
Hyderabad 500007, Andhra Pradesh, India.
Phone: +91-(02764) 278813 | (02764) 278815
Email: yadav@iict.res.in
Andrew J. Peat, Ph.D, Scientific Director,
Antiviral DPU (US), RD Infectious Disease R&D(GSK), RTP, NC, United States,
Tel +1 919 483 6137, Cell +1 919 753 8121
Email: andy.j.peat@gsk.com
Janos Botyanszki, Ph.D, Chief Scientist
Antiviral DPU (US), RD Infectious Disease R&D(GSK), RTP, NC, United States
Tel +1 919 483 3745, Cell +1 510 552 9897
Email: janos.4.botyanszki@gsk.com